Abbonarsi

Waist to height ratio in nonalcoholic fatty liver disease – Systematic review and meta-analysis - 11/08/23

Doi : 10.1016/j.clinre.2023.102160 
Abdulrahman Ismaiel a, Blal El Hosiny b, Mohamed Ismaiel c, Daniel-Corneliu Leucuta d, , Stefan-Lucian Popa a, Cristina Sorina Catana e, Dan L. Dumitrascu a
a 2nd Department of Internal Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania 
b Faculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania 
c Cardiothoracic Surgery department, Royal Victoria Hospital, Belfast, United Kingdom 
d Department of Medical Informatics and Biostatistics, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania 
e Department of Medical Biochemistry, "Iuliu Haţieganu" University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania 

Corresponding author at: Department of Medical Informatics and Biostatistics, "Iuliu Hatieganu" University of Medicine and Pharmacy, 6 Pasteur Street, 400349 Cluj-Napoca, Romania.Department of Medical Informatics and BiostatisticsIuliu Hatieganu" University of Medicine and Pharmacy6 Pasteur StreetCluj-Napoca400349Romania

Highlights

WHtR is significantly increased in NAFLD patients compared to controls.
Compared to male NAFLD patients, female NAFLD patients present higher WHtR.
WHtR's accuracy in predicting NAFLD is considered acceptable in comparison to other presently suggested scores.
WHtR can be used in clinical practice as a simple non-invasive score to predict NAFLD.

Il testo completo di questo articolo è disponibile in PDF.

Abstract

Background and Aims

Current nonalcoholic fatty liver disease (NAFLD) guidelines do not provide any recommendations regarding the waist-to-height ratio (WHtR), a simple obesity metric calculated by dividing waist circumference by height. Therefore, we performed a systematic review and meta-analysis aiming to evaluate WHtR in NAFLD.

Methods

We performed a systematic electronic search on PubMed, Embase, and Scopus, identifying observational studies assessing WHtR in NAFLD. QUADAS-2 tool was used to evaluate the quality of included studies. The two main statistical outcomes were the area under the curve (AUC) and the mean difference (MD).

Results

We included a total of 27 studies in our quantitative and qualitative synthesis, with a total population of 93,536 individuals. WHtR was significantly higher in NAFLD patients compared to controls with an MD of 0.073 (95% CI 0.058 - 0.088). This was also confirmed after conducting a subgroup analysis according to the hepatic steatosis diagnosis method, for ultrasound (MD 0.066 [96% CI 0.051 - 0.081]) and transient elastography (MD 0.074 [96% CI 0.053 – 0.094]). Moreover, NAFLD male patients presented significantly lower WHtR compared to female patients (MD -0.022 [95% CI -0.041 – -0.004]). The AUC of WHtR for predicting NAFLD was 0.815 (95% CI 0.780 – 0.849).

Conclusions

WHtR is considerably higher in NAFLD patients compared to controls. Female NAFLD patients present higher WHtR compared to NAFLD male patients. In comparison to other presently suggested scores and markers, the WHtR's accuracy in predicting NAFLD is considered acceptable.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Non-alcoholic fatty liver disease (NAFLD), Metabolic-dysfunction-associated fatty liver disease (MAFLD), Hepatic steatosis, Non-invasive scores


Mappa


© 2023  Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 47 - N° 7

Articolo 102160- Agosto 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Factors associated with discordance in the assessment of fibrosis stage between transient elastography and liver biopsy in NAFLD patients
  • Meng Lu, Mingyu Zhu, Hu Li, Qingling Wang, Yuting Qian, Mingjie Wang, Li Chen
| Articolo seguente Articolo seguente
  • Bariatric surgery and liver transplantation, here we are now: A French nationwide retrospective study
  • Jérôme Dumortier, Domitille Erard, François Villeret, François Faitot, Christophe Duvoux, Stéphanie Faure, Claire Francoz, Jean Gugenheim, Jean Hardwigsen, Jean-Baptiste Hiriart, Pauline Houssel-Debry, Arnaud Del Bello, Guillaume Lassailly, Claire Vanlemmens, Faouzi Saliba, Clara Altman, Marianne Latournerie, Sébastien Dharancy, Tarek Debs, Groupe de recherche français en Greffe de Foie (GReF2)

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.